These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36650613)

  • 21. Risk factors for hospitalisation due to respiratory syncytial virus infection in children receiving prophylactic palivizumab.
    Chida-Nagai A; Sato H; Sato I; Shiraishi M; Sasaki D; Izumi G; Yamazawa H; Cho K; Manabe A; Takeda A
    Eur J Pediatr; 2022 Feb; 181(2):539-547. PubMed ID: 34417646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of Respiratory Syncytial Virus Infection in Cyanotic Congenital Heart Disease in a Subtropical Area.
    Chiu SN; Shao PL; Chen HC; Lin MT; Huang LM; Kao FY; Huang SK; Wang JK; Wu MH
    J Pediatr; 2016 Apr; 171():25-30.e1. PubMed ID: 26822618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in Respiratory Syncytial Virus and Bronchiolitis Hospitalization Rates in High-Risk Infants in a United States Nationally Representative Database, 1997-2012.
    Doucette A; Jiang X; Fryzek J; Coalson J; McLaurin K; Ambrose CS
    PLoS One; 2016; 11(4):e0152208. PubMed ID: 27050095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pediatric intensive care unit admission due to respiratory syncytial virus: Retrospective multicenter study.
    Kang JM; Lee J; Kim YK; Cho HK; Park SE; Kim KH; Kim MJ; Kim S; Kim YJ
    Pediatr Int; 2019 Jul; 61(7):688-696. PubMed ID: 31107995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lower airway anomalies in children with CATCH 22 syndrome and congenital heart disease.
    Wang CC; Chen SJ; Wu ET; Chen CA; Chiu SN; Lin MT; Lu F; Huang SC; Wu MH; Wang JK
    Pediatr Pulmonol; 2013 Jun; 48(6):587-91. PubMed ID: 22997194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage.
    Romero JR
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S46-54. PubMed ID: 12671452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: a national survey before palivizumab use.
    Prais D; Schonfeld T; Amir J;
    Pediatrics; 2003 Sep; 112(3 Pt 1):548-52. PubMed ID: 12949282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimizing the delivery and use of a new monoclonal antibody in children with congenital heart disease: a successful provincial respiratory syncytial virus prophylaxis program.
    Warren A; Langley JM; Thomas W; Scott J
    Can J Cardiol; 2007 May; 23(6):463-6. PubMed ID: 17487291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary hypertension during respiratory syncytial virus bronchiolitis: a risk factor for severity of illness.
    Kimura D; McNamara IF; Wang J; Fowke JH; West AN; Philip R
    Cardiol Young; 2019 May; 29(5):615-619. PubMed ID: 31104634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Respiratory syncytial virus prophylaxis in children with cardiac disease: a retrospective single-centre study.
    Butt M; Symington A; Janes M; Steele S; Elliott L; Chant-Gambacort C; Mondal T; Paes B
    Cardiol Young; 2014 Apr; 24(2):337-43. PubMed ID: 23628233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nosocomial respiratory syncytial virus infections in the palivizumab-prophylaxis era with implications regarding high-risk infants.
    Ashkenazi-Hoffnung L; Dotan M; Livni G; Amir J; Bilavsky E
    Am J Infect Control; 2014 Sep; 42(9):991-5. PubMed ID: 25179332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective population-based study of RSV-related intermediate care and intensive care unit admissions in Switzerland over a 4-year period (2001-2005).
    Berger TM; Aebi C; Duppenthaler A; Stocker M;
    Infection; 2009 Apr; 37(2):109-16. PubMed ID: 19412586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Follow-up of children with respiratory syncytial virus bronchiolitis in 1986 and 1987: potential effect of ribavirin on long term pulmonary function. The Bronchiolitis Study Group.
    Krilov LR; Mandel FS; Barone SR; Fagin JC
    Pediatr Infect Dis J; 1997 Mar; 16(3):273-6. PubMed ID: 9076814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of respiratory syncytial virus infection in children with congenital heart disease undergoing immunoprophylaxis with palivizumab in Pará state, north region of Brazil.
    de Souza RP; Ribeiro ALR; de Menezes SAF; Machado LFA
    BMC Pediatr; 2019 Aug; 19(1):299. PubMed ID: 31462289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiologic risk factors for respiratory viral infections and immunoprophylaxis for respiratory syncytial virus in young children with congenital heart disease.
    Cabalka AK
    Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S41-5. PubMed ID: 14730269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute respiratory infections in hospitalised infants with congenital heart disease.
    Ahuja N; Mack WJ; Wu S; Wood JC; Russell CJ
    Cardiol Young; 2021 Apr; 31(4):547-555. PubMed ID: 33308367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respiratory morbidity of hospitalized children with Trisomy 21.
    Hilton JM; Fitzgerald DA; Cooper DM
    J Paediatr Child Health; 1999 Aug; 35(4):383-6. PubMed ID: 10457298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease.
    Feltes TF; Cabalka AK; Meissner HC; Piazza FM; Carlin DA; Top FH; Connor EM; Sondheimer HM;
    J Pediatr; 2003 Oct; 143(4):532-40. PubMed ID: 14571236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Respiratory virus prophylaxis in congenital heart disease.
    Joshi M; Tulloh RM
    Future Cardiol; 2018 Sep; 14(5):417-425. PubMed ID: 29877720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of palivizumab on admission to the ICU for respiratory syncytial virus bronchiolitis: a national survey.
    Prais D; Danino D; Schonfeld T; Amir J
    Chest; 2005 Oct; 128(4):2765-71. PubMed ID: 16236953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.